T. MIYASAKA
- Infectious Diseases top 5%
- Virology top 2%
- Molecular Biology
- Organic Chemistry top 10%
- Epidemiology
- Co-authors
- H. TANAKAErik De ClercqMasanori BabaRichard WalkerJan BalzariniDominique ScholsRudi PauwelsHiroshi Nakashima
- Topics
- HIV/AIDS drug development and treatment (12 papers)Chemical Synthesis and Analysis (6 papers)Biochemical and Molecular Research (6 papers)
- Journals
- Biochemical and Biophysical Research CommunicationsAnnals of the New York Academy of SciencesAntimicrobial Agents and Chemotherapy
- Partner nations
- JapanUnited KingdomBelgium
In The Last Decade
T. MIYASAKA
23 papers receiving 555 citations
Peers
Comparison fields: 5 of 57
- Infectious Diseases 364
- Virology 278
- Molecular Biology 220
- Organic Chemistry 167
- Epidemiology 117
Countries citing papers authored by T. MIYASAKA
This map shows the geographic impact of T. MIYASAKA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. MIYASAKA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. MIYASAKA more than expected).
Fields of papers citing papers by T. MIYASAKA
This network shows the impact of papers produced by T. MIYASAKA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. MIYASAKA. The network helps show where T. MIYASAKA may publish in the future.
Co-authorship network of co-authors of T. MIYASAKA
This figure shows the co-authorship network connecting the top 25 collaborators of T. MIYASAKA. A scholar is included among the top collaborators of T. MIYASAKA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. MIYASAKA. T. MIYASAKA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 6 | |
| 3 | 27 | |
| 4 | 2 | |
| 5 | 12 | |
| 6 | [Nucleosides and related compounds which act as inhibitors against replication of HIV-1]. | 1 |
| 7 | 18 | |
| 8 | 0 | |
| 9 | 101 | |
| 10 | 9 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 20 | |
| 14 | 8 | |
| 15 | 250 | |
| 16 | 3 | |
| 17 | Evaluation of the affinity of new N atom-containing tumor inhibitors for nucleic acids. | 2 |
| 18 | Synthesis and pharmacological activities of 2-alkynyl- and 2-alkenyladenine nucleosides. | 1 |
| 19 | Introduction of carbon substituents at C-2 position of purine nucleosides. | 1 |
| 20 | 20 |
About T. MIYASAKA
T. MIYASAKA is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 25 papers that have together received 572 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), Chemical Synthesis and Analysis (6 papers) and Biochemical and Molecular Research (6 papers). The work is most often cited by research in Virology (278 citations), Infectious Diseases (364 citations) and Organic Chemistry (167 citations). T. MIYASAKA has collaborated with scholars based in Japan, United Kingdom and Belgium. Frequent co-authors include H. TANAKA, Erik De Clercq, Masanori Baba, Richard Walker, Jan Balzarini, Dominique Schols, Rudi Pauwels, Hiroshi Nakashima, Carlo Federico Perno and Shirô Shigeta. Their work appears in journals such as Biochemical and Biophysical Research Communications, Annals of the New York Academy of Sciences and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.